Clinical Trials in Tennessee

Showing 12041-12060 of 20,239 trials

Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLC

NCT03326752

This open-label, multicenter, dose-escalation and expansion trial is designed to evaluate the safety and preliminary efficacy of inhaled DV281 in combination with nivolumabfor the treatment of NSCLC and to select a recommended phase 2 dose (RP2D).

Advanced Non Small Cell Lung Cancer

Dynavax Technologies Corporation26 participantsStarted Sep 2017

La Jolla, California, United States • Santa Monica, California, United States • Minneapolis, Minnesota, United States +3 more locations

TERMINATEDPhase 229 miles

A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF

NCT03864328

Idiopathic pulmonary fibrosis (IPF) is a rare, progressive life-threatening disease that is characterized by exertional dyspnea and persistent dry cough. Cough in IPF is both a presenting and a complicating clinical feature, which affects approximately three quarters of IPF cases. It is often a debilitating symptom that adversely affects quality of life (QoL) and is usually refractory to medical therapy. Inhaled RVT-1601 (formerly, PA101B), a new inhalation formulation of cromolyn sodium delivered via the eFlow® Closed System (CS) nebulizer, is being evaluated in this Phase 2b study for the treatment of persistent cough in patients with IPF.

Persistent Cough in IPFChronic CoughIPF

Respivant Sciences GmbH108 participantsStarted Mar 2019

Birmingham, Alabama, United States • Sacramento, California, United States • San Francisco, California, United States +78 more locations

Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLC

A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF

Find Trials by Condition in Tennessee

A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis

Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD)

A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer

A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis

Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)

Measurement of NonInvasive Blood Pressure in Neonates Through Adults and Special Populations

Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD

A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura

A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease

A Gene Therapy Study for Hemophilia B

Phoenix Post-Approval Registry - Using the Phoenix Atherectomy Systems

Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO)

Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH

Phase 1/2a Dose-Escalation Study of CRLX301 in Patients With Advanced Solid Tumors

GSK2982772 Study in Subjects With Ulcerative Colitis

Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events

An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 Diabetes